Azelastine Hydrochloride Solution/ Drops
Product Images NDC 70069-091
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 70069-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
B6722959 62fd 4637 94ba 6fe4e1bc45f8 02
This is a description of a sterile ophthalmic solution containing Azelastine HCI. The usual dosage is one drop per affected eye twice a day. The product comes in a 6mL bottle and needs to be stored upright between 2 and 25°C. It is for use in the eyes only and requires a prescription. The manufacturer is Somerset Therapeutics, LLC, and the product is made in India. Full prescribing information is available in the packaging insert. No information is available regarding a Varnish Area.*
B6722959 62fd 4637 94ba 6fe4e1bc45f8 03
This is a description of a medication called "Azelastine HCI Ophthalmic Solution, USP" manufactured by Somerset Therapeutics LLC. It is a prescription drug used for the treatment of allergic conjunctivitis. It comes as a sterile solution containing 0.5 mg of azelastine hydrochloride per mL, with benzalkonium chloride as a preservative. The recommended dosage is one drop in each affected eye twice daily. The medication should be stored upright between 2°C and 25°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.